Literature DB >> 12426279

Distribution of calibrated talc after intrapleural administration: an experimental study in rats.

Anne Fraticelli1, Andrée Robaglia-Schlupp, Helene Riera, Suzanne Monjanel-Mouterde, Pierre Cau, Philippe Astoul.   

Abstract

STUDY
OBJECTIVE: Many reports have shown that talc is the most effective and least expensive agent for the creation of a pleural symphysis. However, its use still remains controversial due to severe acute respiratory side effects possibly related to the systemic dissemination of talc particles. The purpose of this study was to assess the distribution of calibrated talc after intrapleural administration in rats. MATERIAL AMD
METHODS: Thirty-seven Wistar male rats were randomly assigned to undergo pleurodesis by talc slurry (33 rats) or by simple chest tube drainage (control group; 4 rats). Forty milligrams of calibrated talc suspended in 1 mL sterile saline solution was injected into rats in the treated group. The animals were randomly assigned for autopsy at 24 or 72 h after pleural injection. Lungs, parietal pleura, diaphragm, liver, kidneys, spleen, pericardium, brain, and blood were assessed by polarized light for birefringent talc particle detection and counting.
RESULTS: No deaths were observed. The autopsies showed no pleurodesis at 24 and 72 h. Despite high doses of talc (extrapolated from the dose of 10 g in a 70-kg adult man), few talc particles were found in the liver of two rats, in the spleen of one rat, and only one particle of talc was observed at the brain surface of the rat studied by scanning electron microscopy. No particles were found in the other organs, in particular in the contralateral lung and blood, contrasting with previously published results using noncalibrated talc particles.
CONCLUSIONS: The lack of systemic dispersion of talc particles, with the packaging talc we currently use in our clinical practice, is probably due to the size of the talc particles, which are larger than the other talc preparations. Calibrated talc is required in case of intrapleural administration for pleurodesis to avoid systemic dissemination and potential secondary acute respiratory failures.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12426279     DOI: 10.1378/chest.122.5.1737

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

Review 1.  Management of malignant pleural effusion.

Authors:  Jack A Kastelik
Journal:  Lung       Date:  2013-01-13       Impact factor: 2.584

2.  Treatment of primary spontaneous pneumothorax by videothoracoscopic talc pleurodesis under local anesthesia: a review of 133 procedures.

Authors:  R Ramos-Izquierdo; J Moya; I Macia; F Rivas; A Ureña; G Rosado; I Escobar; J Saumench; A Cabrera; M A Delgado; R Villalonga
Journal:  Surg Endosc       Date:  2009-09-30       Impact factor: 4.584

3.  Talc pleurodesis for secondary pneumothorax in elderly patients with persistent air leak.

Authors:  Takuya Watanabe; Ichiro Fukai; Katsuhiro Okuda; Satoru Moriyama; Hiroshi Haneda; Osamu Kawano; Keisuke Yokota; Masayuki Shitara; Tsutomu Tatematsu; Tadashi Sakane; Risa Oda; Ryoichi Nakanishi
Journal:  J Thorac Dis       Date:  2019-01       Impact factor: 2.895

4.  Comparison of side effects of oxytetracycline and talc pleurodesis: an experimental study.

Authors:  Alper Gözübüyük; Berkant Ozpolat; Ali Fuat Ciçek; Hasan Caylak; Orhan Yücel; Kuthan Kavaklı; Sedat Gürkök; Onur Genç
Journal:  J Cardiothorac Surg       Date:  2010-12-13       Impact factor: 1.637

5.  Prevention of pleural adhesions by bioactive polypeptides - a pilot study.

Authors:  D Åkerberg; M Posaric-Bauden; K Isaksson; R Andersson; B Tingstedt
Journal:  Int J Med Sci       Date:  2013-10-08       Impact factor: 3.738

6.  Efficacy of mistletoe for chemical pleurodesis in rats without malignancy.

Authors:  Hyo Yeong Ahn; Jeong Su Cho; Yeong Dae Kim; Hoseok I; Yeon Ji Kim; Ahrong Kim; Chang Hun Lee
Journal:  Open Med (Wars)       Date:  2015-09-04

7.  Pleurodesis by erythromycin, tetracycline, Aerosil™ 200, and erythromycin plus Aerosil™ 200 in a rat model: a preliminary study.

Authors:  Shahryar Hashemzadeh; Khosrow Hashemzadeh; Kamran Mamaghani; Elnaz Ansari; Raheleh Aligholipour; Samad Ej Golzari; Kamyar Ghabili
Journal:  Daru       Date:  2012-11-26       Impact factor: 3.117

8.  Chest ultrasonography to assess the kinetics and efficacy of talc pleurodesis in a model of pneumothorax: an experimental animal study.

Authors:  Rachid Tazi-Mezalek; Diane Frankel; Marc Fortin; Elise Kaspi; Julien Guinde; Alexandra Assolen; Sophie Laroumagne; Andree Robaglia; Herve Dutau; Patrice Roll; Philippe Astoul
Journal:  ERJ Open Res       Date:  2018-06-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.